The levonorgestrel intrauterine system (Mirena) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction

I. Lete, Iñaki Lete, C. Obispo, F. Izaguirre, Teresa Orte, T Orte, B. Rivero, Ma Jesús Cornellana, M J Cornellana, Isabel García-Bermejo, I Bermejo, on behalf of the Spanish Society of, Spanish Society of Gynaecology Obstetrics (SEGO)
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception · 2008 · vol. 13(3) , pp. 231–237 · doi:10.1080/13625180802075075 · PMID:18609346 · W2079340219
Other OA: closed CC0 ⤵ 6 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

The levonorgestrel intrauterine system (LNG-IUS) significantly reduced bleeding, improved quality of life, and achieved high patient satisfaction in women with idiopathic menorrhagia.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVES: To evaluate patient satisfaction and improvement in quality of life (QoL) among women with idiopathic menorrhagia treated with the levonorgestrel intrauterine system (LNG-IUS). STUDY DESIGN: Prospective-observational study with one-year follow-up in which 225 women were enrolled who had a LNG-IUS inserted for control of idiopathic menorrhagia. Bleeding, tolerability, user satisfaction, and health-related QoL (by means of the SF-36 QoL questionnaire) were assessed. RESULTS: There was a statistically significant reduction in the amount of bleeding, an increase of haemoglobin and ferritin levels, and an improved QoL score. A high degree of satisfaction was reported by over 98% of patients. CONCLUSIONS: The LNG-IUS is an effective and well-tolerated treatment modality in idiopathic menorrhagia. The QoL of women treated with the LNG-IUS is markedly improved, causing high levels of patient satisfaction. This IUS can be regarded as a first-choice therapy in idiopathic menorrhagia.

My notes (saved in your browser only)

MeSH descriptors

Contraceptive Agents, Female Levonorgestrel Menorrhagia Patient Satisfaction Quality of Life Adult Contraceptive Agents, Female Contraceptive Agents, Female Female Ferritins Ferritins Follow-Up Studies Hemoglobins Hemoglobins Humans Intrauterine Devices, Medicated Levonorgestrel Levonorgestrel Menorrhagia Menorrhagia

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (14)

Cited by (6)

Source provenance

openalex
last seen: 2026-05-11T06:14:16.517584+00:00
pubmed
last seen: 2026-10-08T21:05:36.063128+00:00
unpaywall
last seen: 2026-10-14T06:23:58.021457+00:00
License: CC0 · commercial use OK